eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Comment on FR Doc # 2011-21012

Comment on FR Doc # 2011-21012

Document ID: IRS-2011-0025-0006
Document Type: Public Submission
Agency: Internal Revenue Service
Received Date: November 14 2011, at 12:00 AM Eastern Standard Time
Date Posted: November 14 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 18 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 16 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f6b89a
View Document:  View as format xml

This is comment on Proposed Rule

Branded Prescription Drug Fee

View Comment

See attached file(s)

Attachments:

Glaxosmithkline Comments

Title:
Glaxosmithkline Comments

View Attachment: View as format pdf

Related Comments

    View All
Total: 17
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/14/2011     ID: IRS-2011-0025-0006

Nov 16,2011 11:59 PM ET
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/15/2011     ID: IRS-2011-0025-0007

Nov 16,2011 11:59 PM ET
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/16/2011     ID: IRS-2011-0025-0009

Nov 16,2011 11:59 PM ET
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/16/2011     ID: IRS-2011-0025-0011

Nov 16,2011 11:59 PM ET
Branded Prescription Drug Fee
Public Submission    Posted: 11/16/2011     ID: IRS-2011-0025-0012

Nov 16,2011 11:59 PM ET